TORONTO, Oct. 12, 2017 /CNW/ - Professor Ronald Li, CEO & Scientific Co-Founder, Novoheart Holdings Inc., joined Rob Peterman, Vice-President, Global Business Development, TMX Group, to open the market. Novoheart is a global stem cell biotechnology company dedicated to human heart engineering with offices in Vancouver, British Columbia, the United States and Hong Kong. Novoheart Holdings Inc. commenced trading on TSX Venture Exchange on October 3, 2017.

Novoheart Holdings Inc. Opens the Market (CNW Group/TMX Group Limited)

SOURCE TMX Group Limited

Copyright 2017 Canada NewsWire

Novoheart (TSXV:NVH)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Novoheart Charts.
Novoheart (TSXV:NVH)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Novoheart Charts.